Efficacy of Different Beta-Blockers in the Treatment of Long QT Syndrome

26.09.20141882
Do different beta-blockers vary in efficacy in reducing the risk of cardiac events in long QT syndrome (LQTS) and in genotype-positive LQT1 and LQT2 patients?

Key Updates for Angina, NSTEMI

25.09.20142077
The American Heart Association and American College of Cardiology released an update of their guidelines for unstable angina and non-ST segment elevation myocardial infarction (NSTEMI).

Short-term amiodarone therapy after reversion of persistent atrial fibrillation reduces recurrences at 18 months

24.09.20141468
The aim of this study was to compare the outcome of 3 months vs. 18 months of amiodarone treatment after atrial fibrillation (AF) conversion in patients who experienced the first episode of persistent AF.

2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

23.09.20142435
This guideline statement from the European Society of Cardiology discusses the appropriate diagnosis and management strategies for acute pulmonary embolism (PE). The following are eleven key points from the guideline statement.

Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention: A Contemporary Review

22.09.20141929
This review discusses the evidence base for the management of patients on a VKA, and who are undergoing PCI.

2014 ESC/EACTS Guidelines on Myocardial Revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

18.09.20143443
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Intracoronary Injection of CD34+-Cells in Chronic Ischemic Heart Failure: 7 Years Follow-Up of the DanCell Study

17.09.20141531
Seven years ago, the DanCell study was carried out to test the hypothesis of improvement in left ventricular ejection fraction (LVEF) following repeated intracoronary injections of autologous bone marrow-derived stem cells (BMSCs) in patients suffering from chronic ischemic heart failure.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.